Phuoc Tran, MD
Radiation Oncology · Houston, TXNPI 1376739037
Payments from drug & device makers
Across 131 payments — averaging $7374.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bayer$569K
- Astellas Pharma Global Development$258K
- Janssen Research & Development, LLC$95K
- Astellas Pharma US Inc$22K
- Pfizer$8K
- Regeneron$6K
- plus $8K from 10 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bayer | 50 | $569,272 |
| Astellas Pharma Global Development | 6 | $257,516 |
| Janssen Research & Development, LLC | 28 | $94,707 |
| Astellas Pharma US Inc | 5 | $21,803 |
| Pfizer | 5 | $8,145 |
| Regeneron | 5 | $6,158 |
| Astrazeneca UK Limited | 1 | $3,250 |
| Novartis | 2 | $2,483 |
| Siemens Medical Solutions USA, Inc. | 16 | $1,745 |
| Johnson & Johnson | 6 | $572 |
| GT Medical Technologies, Inc | 1 | $144 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $134 |
| Reflexion Medical, Inc. | 2 | $97 |
| Myovant Sciences Inc. | 1 | $28 |
| Bioprotect Medical, Inc. | 1 | $25 |
| Genentech, Inc. | 1 | $11 |
How this compares
$966,091 in reported general payments places this provider in the 95th percentile of 418 radiation oncology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other radiation oncology in Houston
- Daniel GomezHouston$8.7M
- Chad TangHouston$7.7M
- James WelshHouston$5.1M
- Caroline ChungHouston$3.7M
- Karen HoffmanHouston$2.6M
- Clifton FullerHouston$1.6M
- Steven LinHouston$1.5M
- Chenyang WangHouston$1.4M
- Joe ChangHouston$1.2M
- Lilie LinHouston$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.